Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy
Man Kyu Shim, Yujeong Moon, Suah Yang, et al.
Biomaterials (2020) Vol. 261, pp. 120347-120347
Closed Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

In Situ Self‐Assembly Supramolecular Antagonist Reinforces Radiotherapy by Inhibiting Tumor Apoptosis Evasion
Xiaoxue Hou, Lijun Yang, Paiyun Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 36
Closed Access | Times Cited: 16
Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors
Hanhee Cho, Kwangmeyung Kim
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 627-638
Closed Access | Times Cited: 6
The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis
Jinseong Kim, Man Kyu Shim, Young‐Jae Cho, et al.
Biomaterials (2021) Vol. 279, pp. 121189-121189
Closed Access | Times Cited: 40
Cathepsin B-responsive multifunctional peptide conjugated gold nanorods for mitochondrial targeting and precise photothermal cancer therapy
Xiao‐Kang Jin, Yang Huang, Zhengwei Mao, et al.
Journal of Colloid and Interface Science (2021) Vol. 601, pp. 714-726
Closed Access | Times Cited: 34
Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
Mohamed Haider, Amr Elsherbeny, Valeria Pittalà, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1853-1853
Open Access | Times Cited: 26
Advances in nanobiotechnology-propelled multidrug resistance circumvention of cancer
Jie Chen, Xin Yu, Xinyu Liu, et al.
Nanoscale (2022) Vol. 14, Iss. 36, pp. 12984-12998
Closed Access | Times Cited: 22
Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment
Vera S. Egorova, Ekaterina Kolesova, Manu Lopus, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1848-1848
Open Access | Times Cited: 13
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
Jinseong Kim, Man Kyu Shim, Yujeong Moon, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Cathepsin B Activatable Fluorescent Probe for Antitumor Efficiency Feedback: Attempt To Detect Certain Apoptotic Cells
Qiqi Yu, Dongdong Xu, Sina Chen, et al.
Analytical Chemistry (2025)
Closed Access
Rational design of peptides to overcome drug resistance by metabolic regulation
Min Sun, Le He, Ran Chen, et al.
Drug Resistance Updates (2025), pp. 101208-101208
Closed Access
Nanoscale strategies: doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches
Jian Xin Lim, Yoke Keong Yong, Firli Rahmah Primula Dewi, et al.
Drug Delivery and Translational Research (2025)
Closed Access
How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery? A Comprehensive Review of the Literature
Hamdi Nsairat, Zainab Lafi, Belal O. Al-Najjar, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2133-2161
Open Access
Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy
Suah Yang, In‐Cheol Sun, Hee Sook Hwang, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 19, pp. 3983-4001
Closed Access | Times Cited: 32
Cathepsin B-Activated Fluorescent and Photoacoustic Imaging of Tumor
Xiaoxia Chen, Xingxing Ren, Yuhan Zhu, et al.
Analytical Chemistry (2021) Vol. 93, Iss. 27, pp. 9304-9308
Closed Access | Times Cited: 31
Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment
Mengjun Zhang, Huiyang Jiang, Lan Wu, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 422-437
Closed Access | Times Cited: 21
Beyond basic research: the contribution of cathepsin B to cancer development, diagnosis and therapy
Andrey A. Zamyatnin, Levy C Gregory, Paul A. Townsend, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 11, pp. 963-977
Open Access | Times Cited: 21
Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy
Nayeon Shim, Seong Ik Jeon, Suah Yang, et al.
Biomaterials (2022) Vol. 289, pp. 121806-121806
Closed Access | Times Cited: 20
Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy
Yujeong Moon, Hanhee Cho, Kwangmeyung Kim
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 795-795
Open Access | Times Cited: 4
Peptide-modified nanoparticles for doxorubicin delivery: Strategies to overcome chemoresistance and perspectives on carbohydrate polymers
Han Xu, Xue Zhang, Lixing Kang, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140143-140143
Closed Access
Progress of extracellular vesicles-based system for tumor therapy
Fei Wang, Le Yin, Yong Hu
Journal of Controlled Release (2025)
Closed Access
Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy
Man Kyu Shim, Jinhee Na, In Kyung Cho, et al.
Journal of Controlled Release (2021) Vol. 331, pp. 434-442
Closed Access | Times Cited: 25
Multifunctional building elements for the construction of peptide drug conjugates
Xu Liu, Shan Xu, Tangyong Xiang, et al.
Engineered Regeneration (2022) Vol. 3, Iss. 1, pp. 92-109
Open Access | Times Cited: 17
Cathepsins in the extracellular space: Focusing on non-lysosomal proteolytic functions with clinical implications
Hailong Wang, Aiko Inoue, Yanna Lei, et al.
Cellular Signalling (2022) Vol. 103, pp. 110531-110531
Closed Access | Times Cited: 16
In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity
Hyeyoun Chang, Ji Young Yhee, Sangmin Jeon, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Advance Progress in Assembly Mechanisms of Carrier-Free Nanodrugs for Cancer Treatment
Xiaoyu Zhang, S. Hu, Lifei Huang, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7065-7065
Open Access | Times Cited: 9

Scroll to top